MICROPLEGY DISPENSING SYSTEM

DE602021024588T2Active Publication Date: 2025-01-08TERUMO CARDIOVASCULAR SYSTEMS CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE602021024588
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-08-13
Filing Date
2021-08-02
Publication Date
2025-01-08
Estimated Expiration
2041-08-02

AI Technical Summary

Technical Problem

Traditional cardioplegia systems in heart/lung machines use large volumes of crystalloid solutions, leading to hematocrit concentration drops and complications that require hemoconcentration or packed red blood cells, which can cause additional issues during open-heart surgery.

Method used

A microplegia delivery system using syringe pumps to directly administer cardioplegia agents into the blood-carrying portion of the cardioplegia circuit, allowing precise control of drug delivery without crystalloid dilution, with coordinated flow rates linked to real-time blood flow rates and adjustable drug-to-blood ratios.

Benefits of technology

Minimizes the amount of cardioplegia agents used, maintains blood concentration, and allows for efficient delivery of short half-life medications close to the surgical site, reducing complications and enhancing medication efficacy.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.